science π¬ Oligo drugs moving past rare diseases
Advances in chemistry and delivery are significantly reshaping therapeutic oligonucleotides as genetic medicines. These molecules are being studied by authors in a recent review published in Cell Reports Medicine. As of the writing, 21 therapeutic oligonucleotides received regulatory approval, with two later being withdrawn. Chemical modifications and delivery strategies are improving efficacy, though liver delivery remains a focus. Future work is exploring targeted delivery beyond the liver for broader applications. π§¬